On March 26, 2026, Viskase Holdings, Inc. (formerly known as Enzon Pharmaceuticals, Inc.) announced the successful completion of its merger with Viskase Companies, Inc. This all-stock transaction marks a significant milestone for the company, which will now operate under the name Viskase Holdings, Inc. The merger was executed through a subsidiary of Viskase Holdings, with Viskase Companies becoming a wholly owned subsidiary. Following the merger, Viskase transitioned into a limited liability company under Delaware law. As part of the merger agreement, stockholders of Enzon will own approximately 45% of the combined company, while Viskase stockholders will hold about 55%. The common stock of the newly formed entity will begin trading on the OTCQB under the temporary symbol 'ENZND' for the next 20 trading days. This merger is expected to enhance Viskase's operational capabilities and market presence, positioning it for future growth in the non-edible casing market, which serves major global consumer products companies. The completion of this merger is anticipated to provide strategic advantages and operational synergies, allowing the combined company to better serve its customers and expand its market reach.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.